Early diagnosis of cardiac dysfunction offers the opportunity for early medical therapy such as ACE inhibitors to prevent clinical CHF, an intervention shown to be clinically effective in other populations such as post MI patients. The gene discussed is ACE; the disease is myocardial infarction.